Efficacy of antioxidant therapies in transient focal ischemia in mice

Stroke

Volumn 32, Issue 4, 2001, Pages 1000-1004

  Clark, Wayne M ^a,c   Rinker, Lisa G ^a   Lessov, Nikola S ^a   Lowery, Stuart L ^a   Cipolla, Marilyn J ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Animal models; Antioxidants; Mice; Neuroprotection; Oxygen radical

Indexed keywords

FREE RADICAL; GINKGO BILOBA EXTRACT; PLACEBO; SILICONE; THIOCTIC ACID; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROLOGICAL COMPLICATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REPERFUSION INJURY; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

GINKGO BILOBA;

EID: 0035075997     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.4.1000     Document Type: Article

References (38)

1. Background review and current concepts of reperfusion injury
2. Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats
3. Reperfusion damage following focal ischemia: Pathophysiology and therapeutic windows
4. Natural substances in psychiatry (Ginkgo biloba in dementia)
5. Ginkgo biloba extract (EGb 761)
6. Anti-inflammatory substances of plant origin
7. Ginkgo biloba
8. Cardioprotective and antioxidant effects of the terpenoid constituents of ginkgo biloba extract (EGb 761)
9. Dihydrolipoate reduces neuronal injury after cerebral ischemia
10. The pharmacology of the lipoic acid
11. Determination of cell-cell adhesion in response to oxidants and antioxidants
12. Neuroprotective effects of lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia
13. Dihydrolipoate reduces neuronal injury after cerebral ischemia
14. Experimental studies of ischemic brain edema, I: A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area
15. Monofilament intraluminal middle cerebral artery occlusion in the mouse
16. Doxycycline treatment reduces ischemic brain damage in transient middle cerebral artery occlusion in the rat
17. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats
18. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat
19. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat
20. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat
21. Direct measurement of free radicals in ischemic/reperfused diabetic rat retina
22. Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo and some flavonoids
23. Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism
24. Is there a case for PAF antagonist in the treatment of ischemic states?
25. Plasma-mediated neutrophil activation during acute myocardial infarction: Role of platelet-activating factor
26. Inhibition of radiation-induced up-regulation of leukocyte adhesion to endothelial cells with the platelet-activating factor inhibitor, BN52021
27. PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat
28. Ginkgo biloba und hirnleistungsstorungen
29. Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats
30. The effect of a platelet activating factor antagonist (BN-52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia
31. Gingko biloba for cerebral insufficiency
32. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type: A double-blind, placebo-controlled study on different levels of investigation
33. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia
34. A placebo-controlled, double-blind, randomized trial of an extract of Gingko biloba for dementia
35. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion
36. Determination of cell-cell adhesion in response to oxidants and antioxidants
37. α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats
38. Alpha-lipoic acid provides neuroprotection from ischemia-reperfusion injury of peripheral nerve